Argatroban as a substitute of heparin during cardiopulmonary bypass: A safe alternative?

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 4, 2010, Pages 592-596

  Follis, Fabrizio ^a   Filippone, Gianfranco ^a   Montalbano, Giuseppe ^a   Floriano, Maria ^a   LoBianco, Ettore ^a   D'Ancona, Giuseppe ^b   Follis, Marco ^a  

^a ARNAS   (Italy)

^b MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

Blood coagulation anticoagulation; Cardiopulmonary bypass; Physiology pathophysiology

Indexed keywords

ARGATROBAN; FRESH FROZEN PLASMA; HEPARIN; THROMBIN INHIBITOR; TRANEXAMIC ACID;

ADULT; ANTICOAGULATION; AORTA CLAMPING; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; CONGESTIVE HEART FAILURE; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG SAFETY; DRUG UTILIZATION; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FEMALE; HEART CATHETERIZATION; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL DISCHARGE; HUMAN; MEDICAL LITERATURE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; OXYGENATOR; PATIENT MONITORING; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THORACOTOMY; THROMBOCYTE TRANSFUSION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PIPECOLIC ACIDS; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; THROMBIN; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 77950633449     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.215848     Document Type: Article

References (22)

1. Follis F, Schmidt C. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis. Ann Thorac Surg 2000;70: 2173-2181.
2. Warkentin T, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003;76:2121-2131.
3. Hursting M, Dubb J, Verme-Gibboney CN. Argatroban anticoagulation in pediatric patients. A literature analysis. J Pediatr Hematol Oncol 2006; 28:4-10.
4. Martin M, Kloecker G, Laber D. Argatroban for anticoagulation during cardiac surgery. Eur J Haematol 2007;78:161-166.
5. Swan SK, Hursting MJ. The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy 2000;20:318-329.
6. Swan S, St. Peter J, Lambrecht L, Hursting M. Comparison of antico-agulant effects and safety of argatroban and heparin in healthy subjects. Pharmacotherapy 2000;2:756-770.
7. Furukawa K, Ohteki H, Hirahara K, Narita Y, Koga S. The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations. Thorac Cardiovasc Surg 2001;122:1255-1256.
8. Edwards J, Hamby J, Neil K, Worrall N. Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient. Ann Thorac Surg 2003;75:1622-1624.
9. Kamei M, Miyata S, Niwaya K, Bando K, Tsuji T, Suzuki S, Hanatani A, Ohnishi Y, Uchida O, Kuro M, Imanaka H, Kobayashi J, Yagihara T, Nakatani T. Successful argatroban anticoagulant management for left ventricular assist system implantation in two patients with heparin-induced thrombocytopenia type II. J Thromb Hemost 2003;(Suppl 1):abstract number P1162.
10. Malherbe S, Tsui B, Stobart K, Koller J. Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII. Anesthesiology 2004;100:443-445.
11. Gasparovic H, Nathan N, Fitzgerald D, Aranki S. Severe argatroban induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia. Ann Thorac Surg 2004;78:e89-e91.
12. Dyke II P, Russo P, Mureebe L, Russo J, Tobias J. Argatroban for anticoagulation during cardiopulmonary bypass in an infant. Pediatr Anesth 2005;15:328-333.
13. Mejak B, Giacomuzzi C, Shen I, Boshkov L, Ungerleider R. Cardiopulmonary bypass using argatroban as an anticoagulant for a 6.0-kg pediatric patient. J Extra Corpor Technol 2005;37:303-305.
14. Kurup V, Transue S, Wu Y, Rinder HM, Barash P, Dewar M. Cardiac surgery in a patient with heparin-induced thrombocytopenia. Cautions with use of the direct thrombin inhibitor, argatroban. Conn Med 2006;70:245-250.
15. Smith AI, Stroud R, Damiani P, Vaynblat M. Use of argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy. Eur J Cardiothorac Surg 2008;34:1113-1114.
16. Ciccolo M, Bernstein J, Collazos J, Achreman R, Restrepo H, Winter J, Krueger J, Evans W. Argatroban anticoagulation for cardiac surgery with cardiopulmonary bypass in an infant with double outlet right ventricle and a history of heparin-induced thrombocytopenia. Congenit Heart Dis 2008;3:299-302.
17. Sakai M, Ohteki H, Narita Y, Naitoh K, Natsuaki M, Itoh T. Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model. Cardiovasc Surg 1999;7:187-194.
18. Harder S, Merz M, Klinkhardt U, Lorenz H, Koster A. Influence of argatroban on coagulation parameters in heparin-induced thrombocy-topenia patients after cardiothoracic surgery. J Thromb Haemost 2007;5:1982-1984.
19. Koster A, Buz S, Hetzer R, Kuppe H, Breddin K, Harder S. Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trial. J Thorac Cardiovasc Surg 2006; 132:699-700.
20. Warkentin T, Greinacher A. Reply to letter to the editor argatroban as a heparin substitute in cases of heparin-induced thrombocytopenia. Ann Thorac Surg 2004;78:2208-2209.
21. Warkentin T, Greinacher A, Koster A, Lincoff A. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2008;133: 340-380.
22. Ohno H, Higashidate M, Yokosuka T. Argatroban as an alternative anticoagulant for patients with heparin allergy during coronary bypass surgery. Heart Vessels 2003;18:40-42.